Scifiniti participated as the Publishing Partner and Exhibitor at the 1st MENA Conference on Living Therapeutics, held at NYU Abu Dhabi from 5–7 November 2025.

The conference was convened by NYUAD faculty and listed Scifiniti as a collaborator (publishing partner and exhibitor), underscoring the role of rigorous, open publishing in advancing living medicines. The three-day event brought together researchers, clinicians, startups, and policymakers for keynotes, panels, workshops, and technical showcases focused on next-generation living therapeutics, clinical translation, and scalable manufacturing.

As a Publishing Partner, Scifiniti highlighted its flagship journal Cell Therapy & Engineering Connect, which serves as a dedicated platform for advancing cell-based and regenerative medicine research. Conference presenters are invited to submit extended versions of their presented abstracts, which will be considered for free publication (APC fully waived) in Cell Therapy & Engineering Connect. All submissions will undergo standard editorial checks and full peer review, ensuring that only high-quality, scientifically sound manuscripts are accepted.

To support authors, Scifiniti is also providing complimentary English editing and professional graphics enhancement, helping presenters convert their conference work into strong publishable papers.

Throughout the event, Scifiniti engaged actively with attendees, explored collaboration opportunities, and reinforced its commitment to supporting the living-therapeutics community through high-quality open-access publishing and meaningful regional partnerships.